2,243 publications from this institution
In critical illness, homeostatic corrections representing the culmination of hundreds of millions of years of evolution, are modulated by the activated glucocorticoid receptor alpha (GR)
Interleukin-6 (IL-6) is a pleiotropic cytokine produced by numerous types of immune and nonimmune cells and is involved in many pathophysiologic mechanisms in humans. Many studies suggest that IL-6 is a putative ‘sleep factor’ and its circadian secretion correlates with sleep/sleepiness. IL-6 is elevated in disorders of excessive daytime sleepiness such as narcolepsy and obstructive sleep apnea. It correlates positively with body mass index and may be a mediator of sleepiness in obesity. Also the secretion of this cytokine is stimulated by total acute or partial short-term sleep loss reflecting the increased sleepiness experienced by sleep-deprived individuals. Studies that evaluated the 24-hour secretory pattern of IL-6 in healthy young adults suggest that IL-6 is secreted in a biphasic circadian pattern with two nadirs at about 08.00 and 21.00, and two zeniths at about 19.00 and 05.00 h. In contrast, following sleep deprivation or in disorders of sleep disturbance, e.g., insomnia, IL-6 peaks during the day and, based on the level of stress system activity, i.e., cortisol secretion, contributes to either sleepiness and deep sleep (low cortisol) or feelings of tiredness and fatigue and poor sleep (high cortisol). In order to address concerns about the potential impact of differences of IL-6 levels between the beginning and the end of the 24-hour blood-drawing experiment, we proceeded with a cosinor analysis of ‘detrended’ data in young and old healthy individuals. This new analysis did not affect the biphasic circadian pattern of IL-6 secretion in young adults, while it augmented the flattened circadian pattern in old individuals in whom the difference was greater. Finally, IL-6 appears to be somnogenic in rats and exhibits a diurnal rhythm that follows the sleep/wake cycle in these animals. We conclude that IL-6 is a mediator of sleepiness and its circadian pattern reflects the homeostatic drive for sleep.
Glucocorticoids stimulate transcription pathways in the placenta and amnion that contribute to labor.
This chapter reviews seismology and site effects to provide background for understanding ground motion characteristics and their influence on the behavior of structures. It discusses earthquake sources, magnitude, and magnitude-recurrence relationships. The chapter also discusses the propagation of ground motion to a site, near-source effects, site amplification, and shaking intensity and its representation using response spectra. Seismology is the field of science that studies earthquakes and the propagation of waves through the earth. A number of signal processing techniques are applied to remove noise and sensor artifacts in order to generate the processed acceleration time histories. Because high-frequency waves attenuate faster with distance, most such far-field recordings will have a lower amplitude vertical component. Duration is a scalar measure of interest, especially when discussing the behavior of cyclically degrading structures.
Incremental dynamic analysis (IDA) is widespread to evaluate the seismic response of structures. It employs one records set scaled to multiple intensity levels (IMLs) to estimate the structural res...
<h3>Objective.</h3> —This article defines stress and related concepts and reviews their historical development. The notion of a stress system as the effector of the stress syndrome is suggested, and its physiologic and pathophysiologic manifestations are described. A new perspective on human disease states associated with dysregulation of the stress system is provided. <h3>Data Sources.</h3> —Published original articles from human and animal studies and selected reviews. Literature was surveyed utilizing MEDLINE and the<i>Index Medicus</i>. <h3>Study Selection.</h3> —Original articles from the basic science and human literature consisted entirely of controlled studies based on verified methodologies and, with the exception of the most recent studies, replicated by more than one laboratory. Many of the basic science and clinical studies had been conducted in our own laboratories and clinical research units. Reviews cited were written by acknowledged leaders in the fields of neurobiology, endocrinology, and behavior. <h3>Data Extraction.</h3> —Independent extraction and cross-referencing by the authors. <h3>Data Synthesis.</h3> —Stress and related concepts can be traced as far back as written science and medicine. The stress system coordinates the generalized stress response, which takes place when a stressor of any kind exceeds a threshold. The main components of the stress system are the corticotropin-releasing hormone and locus ceruleus-norepinephrine/autonomic systems and their peripheral effectors, the pituitary-adrenal axis, and the limbs of the autonomic system. Activation of the stress system leads to behavioral and peripheral changes that improve the ability of the organism to adjust homeostasis and increase its chances for survival. There has been an exponential increase in knowledge regarding the interactions among the components of the stress system and between the stress system and other brain elements involved in the regulation of emotion, cognitive function, and behavior, as well as with the axes responsible for reproduction, growth, and immunity. This new knowledge has allowed association of stress system dysfunction, characterized by sustained hyperactivity and/or hypoactivity, to various pathophysiologic states that cut across the traditional boundaries of medical disciplines. These include a range of psychiatric, endocrine, and inflammatory disorders and/or susceptibility to such disorders. <h3>Conclusions.</h3> —We hope that knowledge from apparently disparate fields of science and medicine integrated into a working theoretical framework will allow generation and testing of new hypotheses on the pathophysiology and diagnosis of, and therapy for, a variety of human illnesses reflecting systematic alterations in the principal effectors of the generalized stress response. We predict that pharmacologic agents capable of altering the central apparatus that governs the stress response will be useful in the treatment of many of these illnesses. (<i>JAMA</i>. 1992;267:1244-1252)
Kirschbaum et al.(1) reported that short-term estradiol treatment enhanced hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system responses to psychosocial stress in men.Subtle gender differences in human HPA axis responses, such as increased ACTH and cortisol secretion after ovine corticotropin-releasing hormone (CRH) are well established (2).Also, human female hypothalami have increased CRH content relative to male hypothalami (3).The authors proposed several potential mechanisms for their observation that estradiol enhanced human HPA axis activity, including reduced brain glucocorticoid receptor function, as previously shown in rats (4).Such an effect would reduce the inhibitory effects of glucocorticoid feedback on CRH and ACTH secretion.A further plausible mechanism for their findings may be direct estradiol receptor-mediated stimulation of CRH synthesis and subsequent secretion.The human CRH gene contains five perfect half-palindromic estrogen responsive elements (EREs) within its 5Ј flanking region.Specific and reproducible estrogen receptor-and ERE-mediated enhancement of the human CRH gene promoter was observed in chloramphenicol acetyltransferase reporter constructs (5).Indeed, estradiol-induced stimulation of CRH gene transcription could account for the enhanced HPA axis responses to stress observed in men given estrogen.It would also explain the exaggerated sympathetic nervous system responses to stress, as CRH neurons from the paraventricular nuclei and the amygdala innervate and stimulate arousal and autonomic nonadrenergic centers (6 -8).Estradiol stimulation of CRH gene transcription may also provide, at least in part, the biological basis for the observation that melancholic depression and anorexia nervosa, both disorders associated with central CRH hypersecretion (9), are more prevalent in women than men.